• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Applied Clinical Intelligence launches iCommittees

Applied Clinical Intelligence launches iCommittees

May 17, 2012
CenterWatch Staff

Applied Clinical Intelligence (ACI), a CRO based in Bala Cynwyd, Penn., has launched iCommittees, a comprehensive business solution for the use of data monitoring committees (DMCs) and endpoint adjudication committees (EACs) in clinical research trials.

The establishment of iCommittees is the result of over a decade of process development and ACI industry leadership in expert committee management.

"When ACI started managing committee-based trials several years ago, we saw a need for increased efficiency and organization," said ACI president Jonathan Seltzer, MD. "As a result, we have developed rock solid processes for managing these trials as well as a staff with deep knowledge in this specialized field."

iCommittees utilizes AIMS, a proprietary, web-based portal system specifically built to support expert committee projects. AIMS facilitates global, seamless interactions between committee members, iCommittees team members and sponsors.

"The goal of our technology infrastructure is to furnish committee members with clinically meaningful displays of data," Seltzer explained. "Ultimately, our specialized technology and highly developed processes make better use of our clients' clinical trial resources."

The arrival of iCommittees corresponds with a growing demand for DMC and EAC involvement in clinical research trials. "Committee use has been growing over the past few years, and I expect it to continue," Seltzer said. "Regulators are relying on committees more because they catch regulatory issues earlier. DMCs safeguard patient safety and EACs provide a level of precision additional to that of a traditional trial. For these reasons, regulators view DMCs and EACs as 'de-risking factors'."

In June, ACI will formally present iCommittees at the annual Drug Information Association conference and discuss the business unit's full service offerings with the public.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing